Literature DB >> 21315192

A founder effect at the EPCAM locus in Congenital Tufting Enteropathy in the Arabic Gulf.

Julie Salomon1, Yolanda Espinosa-Parrilla, Olivier Goulet, Wafa'a Al-Qabandi, Philippe Guigue, Danielle Canioni, Julie Bruneau, Fatema Alzahrani, Saleh Almuhsen, Nadine Cerf-Bensussan, Marc Jeanpierre, Nicole Brousse, Stanislas Lyonnet, Arnold Munnich, Asma Smahi.   

Abstract

Mutations of the EPCAM gene have been recently identified in Congenital Tufting Enteropathy (CTE), a severe autosomal recessive gastrointestinal insufficiency of childhood requiring parenteral nutrition and occasionally intestinal transplantation. Studying seven multiplex consanguineous families from the Arabic peninsula (Kuwait and Qatar) we found that most patients were homozygote for a c.498insC mutation in exon 5. The others carried a novel mutation IVS4-2A→G. Both mutations were predicted to truncate the C-terminal domain necessary to anchorage of EPCAM at the intercellular membrane. Consistently, immunohistochemistry of intestinal biopsies failed to detect the EPCAM protein at the intercellular membrane level. The c.498insC mutation was found on the background of a minimal common haplotype of 473kb suggesting a very old founder effect (5000-6000 yrs).
Copyright © 2011 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21315192     DOI: 10.1016/j.ejmg.2011.01.009

Source DB:  PubMed          Journal:  Eur J Med Genet        ISSN: 1769-7212            Impact factor:   2.708


  16 in total

Review 1.  EPCAM deletion carriers constitute a unique subgroup of Lynch syndrome patients.

Authors:  Marjolijn J L Ligtenberg; Roland P Kuiper; Ad Geurts van Kessel; Nicoline Hoogerbrugge
Journal:  Fam Cancer       Date:  2013-06       Impact factor: 2.375

2.  Functional consequences of EpCam mutation in mice and men.

Authors:  James L Mueller; Matthew D McGeough; Carla A Peña; Mamata Sivagnanam
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-12-12       Impact factor: 4.052

3.  Genetic analysis of Italian patients with congenital tufting enteropathy.

Authors:  Maria d'Apolito; Daniela Pisanelli; Flavio Faletra; Ida Giardino; Maddalena Gigante; Massimo Pettoello-Mantovani; Olivier Goulet; Paolo Gasparini; Angelo Campanozzi
Journal:  World J Pediatr       Date:  2015-12-18       Impact factor: 2.764

4.  Genetic characterization of congenital tufting enteropathy: epcam associated phenotype and involvement of SPINT2 in the syndromic form.

Authors:  Julie Salomon; Olivier Goulet; Danielle Canioni; Nicole Brousse; Julie Lemale; Patrick Tounian; Aurore Coulomb; Evelyne Marinier; Jean-Pierre Hugot; Frank Ruemmele; Jean-Louis Dufier; Olivier Roche; Christine Bodemer; Virginie Colomb; Cécile Talbotec; Florence Lacaille; Florence Campeotto; Nadine Cerf-Bensussan; Andreas R Janecke; Thomas Mueller; Sibylle Koletzko; Jean-Paul Bonnefont; Stanislas Lyonnet; Arnold Munnich; Françoise Poirier; Asma Smahi
Journal:  Hum Genet       Date:  2013-10-19       Impact factor: 4.132

5.  Absence of cell-surface EpCAM in congenital tufting enteropathy.

Authors:  Ulrike Schnell; Jeroen Kuipers; James L Mueller; Anneke Veenstra-Algra; Mamata Sivagnanam; Ben N G Giepmans
Journal:  Hum Mol Genet       Date:  2013-03-05       Impact factor: 6.150

Review 6.  Advances in Evaluation of Chronic Diarrhea in Infants.

Authors:  Jay R Thiagarajah; Daniel S Kamin; Sari Acra; Jeffrey D Goldsmith; Joseph T Roland; Wayne I Lencer; Aleixo M Muise; James R Goldenring; Yaron Avitzur; Martín G Martín
Journal:  Gastroenterology       Date:  2018-04-12       Impact factor: 33.883

7.  Identification of EPCAM mutation: clinical use of microarray.

Authors:  Queenie K-G Tan; Diana M Cardona; Catherine W Rehder; Marie T McDonald
Journal:  Clin Case Rep       Date:  2017-05-10

8.  mTrop1/Epcam knockout mice develop congenital tufting enteropathy through dysregulation of intestinal E-cadherin/β-catenin.

Authors:  Emanuela Guerra; Rossano Lattanzio; Rossana La Sorda; Francesca Dini; Gian Mario Tiboni; Mauro Piantelli; Saverio Alberti
Journal:  PLoS One       Date:  2012-11-28       Impact factor: 3.240

9.  Mutation of EpCAM leads to intestinal barrier and ion transport dysfunction.

Authors:  Philip A Kozan; Matthew D McGeough; Carla A Peña; James L Mueller; Kim E Barrett; Ronald R Marchelletta; Mamata Sivagnanam
Journal:  J Mol Med (Berl)       Date:  2014-12-09       Impact factor: 4.599

Review 10.  Concise Review: The Potential Use of Intestinal Stem Cells to Treat Patients with Intestinal Failure.

Authors:  Sung Noh Hong; James C Y Dunn; Matthias Stelzner; Martín G Martín
Journal:  Stem Cells Transl Med       Date:  2016-09-16       Impact factor: 7.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.